Patent regime and historic developments in India for the life sciences sector

By Arshad Jamil

India has a hard-won reputation as a major producer of generic pharmaceuticals. However, the IP framework around life sciences is evolving, prompting changes within the sector

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

Twitter

14 May 2021

@IAM_Alerts With litigation funding flooding the market and the appropriate damages for a plaintiff receiving more trial focus,… https://t.co/VE9a8cuQS7 Read more

14 May 2021

@IAM_Alerts Finding out who owns a patent is far harder than it should be - and that's a problem https://t.co/EAF6HhNIV2 https://t.co/ttghWlOANH Read more

14 May 2021

@IAM_Alerts Oppo has bought a portfolio of declared wireless SEPs from ZTE - not often we see big Chinese tech names swapping p… https://t.co/DOLT5lxUB2 Read more

13 May 2021

@IAM_Alerts Thousands of existing pharma and medical device patents to have terms shortened, decides Brazilian Supreme Court:… https://t.co/bvvKQcnddx Read more

Find an expert

Björn Rundblom Andersson

Partner

Stockholm, Sweden

Westerberg & Partners Advokatbyrå AB

View full biography

Patent regime and historic developments in India for the life sciences sector

Returning user?

Want to read more?

TAGS

Twitter

Find an expert